Remodeling the Tumor Microenvironment Sensitizes Breast Tumors to Anti-Programmed Death-Ligand 1 Immunotherapy
Crossref DOI link: https://doi.org/10.1158/0008-5472.CAN-18-3060
Published Online: 2019-08-15
Published Print: 2019-08-15
Update policy: https://doi.org/10.1158/crossmark_policy
Clift, Renee
Souratha, Jennifer
Garrovillo, Sheryl A.
Zimmerman, Susan
Blouw, Barbara
Funding for this research was provided by:
Halozyme Therapeutics (No Grant Number)
